Who owns TEVA PHARMACEUTICAL FIN NETH SR GLBL NT 29?

Tip: Access positions for across all investors

Analyze quarterly positions in Teva Pharmaceutical Fin Neth Sr Glbl Nt 29 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Teva Pharmaceutical Fin Neth Sr Glbl Nt 29 stock

Who bought or sold TEVA PHARMACEUTICAL FIN NETH SR GLBL NT 29 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pacer Advisors 140k $150k 0% Mar 2024
 View chart